世界の次世代がん診断装置市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Next Generation Cancer Diagnostic Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A13845 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、次世代がん診断装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。次世代がん診断装置の種類別市場規模（次世代シーケンシング、qPCR・マルチプレックス、ラボオンチップ（LOAC）、タンパク質マイクロアレイ、DNAマイクロアレイ、逆転写酵素PCR（RT-PCR））、用途別市場規模（バイオマーカー開発、CTC分析、プロテオミクス分析、エピジェネティック分析、遺伝子分析）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・次世代がん診断装置の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche Holding Ltd.（Switzerland)、Abbott Laboratories(US)、Siemens Healthcare(Germany)、Agilent Technologies Inc(Germany)、Illumina Inc.(US)、Becton Dickinson and Co.(US)、QIAGEN N.V.(Germany)、Affymetrix Inc.(US)、Johnson & Johnson(US)、Thermo Fisher Scientific Inc.(US)、GE Healthcare(England)、Life Technologies Corp.(US)、Luminex Corp.(US)、Cepheid Inc.(US)、Allegro Diagnostics Corp.(Brazil) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：次世代シーケンシング、qPCR・マルチプレックス、ラボオンチップ（LOAC）、タンパク質マイクロアレイ、DNAマイクロアレイ、逆転写酵素PCR（RT-PCR） ・用途別分析2016年-2026年：バイオマーカー開発、CTC分析、プロテオミクス分析、エピジェネティック分析、遺伝子分析 ・次世代がん診断装置の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・次世代がん診断装置のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・次世代がん診断装置のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・次世代がん診断装置の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・次世代がん診断装置の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Next Generation Cancer Diagnostic Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Next Generation Cancer Diagnostic Devices size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Next Generation Cancer Diagnostic Devices market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Next Generation Cancer Diagnostic Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)

Market segment by Application can be divided into
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis

The key market players for global Next Generation Cancer Diagnostic Devices market are listed below:
Roche Holding Ltd.（Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Next Generation Cancer Diagnostic Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Next Generation Cancer Diagnostic Devices, with price, sales, revenue and global market share of Next Generation Cancer Diagnostic Devices from 2019 to 2021.
Chapter 3, the Next Generation Cancer Diagnostic Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Next Generation Cancer Diagnostic Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Next Generation Cancer Diagnostic Devices market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Next Generation Cancer Diagnostic Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Next Generation Cancer Diagnostic Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Next Generation Cancer Diagnostic Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.2.7 Reverse Transcriptase-PCR (RT-PCR)
1.3 Market Analysis by Application
1.3.1 Overview: Global Next Generation Cancer Diagnostic Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Global Next Generation Cancer Diagnostic Devices Market Size & Forecast
1.4.1 Global Next Generation Cancer Diagnostic Devices Sales in Value (2016-2026))
1.4.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume (2016-2026)
1.4.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Next Generation Cancer Diagnostic Devices Production Capacity Analysis
1.5.1 Global Next Generation Cancer Diagnostic Devices Total Production Capacity (2016-2026)
1.5.2 Global Next Generation Cancer Diagnostic Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Next Generation Cancer Diagnostic Devices Market Drivers
1.6.2 Next Generation Cancer Diagnostic Devices Market Restraints
1.6.3 Next Generation Cancer Diagnostic Devices Trends Analysis
2 Manufacturers Profiles
2.1 Roche Holding Ltd.（Switzerland)
2.1.1 Roche Holding Ltd.（Switzerland) Details
2.1.2 Roche Holding Ltd.（Switzerland) Major Business
2.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product and Services
2.1.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Abbott Laboratories(US)
2.2.1 Abbott Laboratories(US) Details
2.2.2 Abbott Laboratories(US) Major Business
2.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product and Services
2.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Siemens Healthcare(Germany)
2.3.1 Siemens Healthcare(Germany) Details
2.3.2 Siemens Healthcare(Germany) Major Business
2.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product and Services
2.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Agilent Technologies Inc(Germany)
2.4.1 Agilent Technologies Inc(Germany) Details
2.4.2 Agilent Technologies Inc(Germany) Major Business
2.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product and Services
2.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Illumina Inc.(US)
2.5.1 Illumina Inc.(US) Details
2.5.2 Illumina Inc.(US) Major Business
2.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
2.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Becton Dickinson and Co.(US)
2.6.1 Becton Dickinson and Co.(US) Details
2.6.2 Becton Dickinson and Co.(US) Major Business
2.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product and Services
2.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 QIAGEN N.V.(Germany)
2.7.1 QIAGEN N.V.(Germany) Details
2.7.2 QIAGEN N.V.(Germany) Major Business
2.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product and Services
2.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Affymetrix Inc.(US)
2.8.1 Affymetrix Inc.(US) Details
2.8.2 Affymetrix Inc.(US) Major Business
2.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
2.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Johnson & Johnson(US)
2.9.1 Johnson & Johnson(US) Details
2.9.2 Johnson & Johnson(US) Major Business
2.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product and Services
2.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Thermo Fisher Scientific Inc.(US)
2.10.1 Thermo Fisher Scientific Inc.(US) Details
2.10.2 Thermo Fisher Scientific Inc.(US) Major Business
2.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
2.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 GE Healthcare(England)
2.11.1 GE Healthcare(England) Details
2.11.2 GE Healthcare(England) Major Business
2.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product and Services
2.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Life Technologies Corp.(US)
2.12.1 Life Technologies Corp.(US) Details
2.12.2 Life Technologies Corp.(US) Major Business
2.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product and Services
2.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Luminex Corp.(US)
2.13.1 Luminex Corp.(US) Details
2.13.2 Luminex Corp.(US) Major Business
2.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product and Services
2.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Cepheid Inc.(US)
2.14.1 Cepheid Inc.(US) Details
2.14.2 Cepheid Inc.(US) Major Business
2.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
2.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Allegro Diagnostics Corp.(Brazil)
2.15.1 Allegro Diagnostics Corp.(Brazil) Details
2.15.2 Allegro Diagnostics Corp.(Brazil) Major Business
2.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product and Services
2.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Next Generation Cancer Diagnostic Devices Sales by Manufacturer
3.1 Global Next Generation Cancer Diagnostic Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Next Generation Cancer Diagnostic Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Next Generation Cancer Diagnostic Devices Manufacturer Market Share
3.4.2 Top 6 Next Generation Cancer Diagnostic Devices Manufacturer Market Share
3.5 Global Next Generation Cancer Diagnostic Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Next Generation Cancer Diagnostic Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Next Generation Cancer Diagnostic Devices Market Size by Region
4.1.1 Global Next Generation Cancer Diagnostic Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Region (2016-2026)
4.2 North America Next Generation Cancer Diagnostic Devices Revenue (2016-2026)
4.3 Europe Next Generation Cancer Diagnostic Devices Revenue (2016-2026)
4.4 Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue (2016-2026)
4.5 South America Next Generation Cancer Diagnostic Devices Revenue (2016-2026)
4.6 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Next Generation Cancer Diagnostic Devices Sales in Volume by Type (2016-2026)
5.2 Global Next Generation Cancer Diagnostic Devices Revenue by Type (2016-2026)
5.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Next Generation Cancer Diagnostic Devices Sales in Volume by Application (2016-2026)
6.2 Global Next Generation Cancer Diagnostic Devices Revenue by Application (2016-2026)
6.3 Global Next Generation Cancer Diagnostic Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Next Generation Cancer Diagnostic Devices Sales by Type (2016-2026)
7.2 North America Next Generation Cancer Diagnostic Devices Sales by Application (2016-2026)
7.3 North America Next Generation Cancer Diagnostic Devices Market Size by Country
7.3.1 North America Next Generation Cancer Diagnostic Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Next Generation Cancer Diagnostic Devices Sales by Type (2016-2026)
8.2 Europe Next Generation Cancer Diagnostic Devices Sales by Application (2016-2026)
8.3 Europe Next Generation Cancer Diagnostic Devices Market Size by Country
8.3.1 Europe Next Generation Cancer Diagnostic Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Next Generation Cancer Diagnostic Devices Market Size by Region
9.3.1 Asia-Pacific Next Generation Cancer Diagnostic Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Next Generation Cancer Diagnostic Devices Sales by Type (2016-2026)
10.2 South America Next Generation Cancer Diagnostic Devices Sales by Application (2016-2026)
10.3 South America Next Generation Cancer Diagnostic Devices Market Size by Country
10.3.1 South America Next Generation Cancer Diagnostic Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Next Generation Cancer Diagnostic Devices Market Size by Country
11.3.1 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Next Generation Cancer Diagnostic Devices Typical Distributors
12.3 Next Generation Cancer Diagnostic Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Next Generation Cancer Diagnostic Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Next Generation Cancer Diagnostic Devices Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Holding Ltd.（Switzerland) Basic Information, Manufacturing Base and Competitors
Table 4. Roche Holding Ltd.（Switzerland) Major Business
Table 5. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product and Services
Table 6. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Laboratories(US) Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories(US) Major Business
Table 9. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 10. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Siemens Healthcare(Germany) Basic Information, Manufacturing Base and Competitors
Table 12. Siemens Healthcare(Germany) Major Business
Table 13. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product and Services
Table 14. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Agilent Technologies Inc(Germany) Basic Information, Manufacturing Base and Competitors
Table 16. Agilent Technologies Inc(Germany) Major Business
Table 17. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product and Services
Table 18. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Illumina Inc.(US) Basic Information, Manufacturing Base and Competitors
Table 20. Illumina Inc.(US) Major Business
Table 21. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 22. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Becton Dickinson and Co.(US) Basic Information, Manufacturing Base and Competitors
Table 24. Becton Dickinson and Co.(US) Major Business
Table 25. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 26. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. QIAGEN N.V.(Germany) Basic Information, Manufacturing Base and Competitors
Table 28. QIAGEN N.V.(Germany) Major Business
Table 29. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product and Services
Table 30. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Affymetrix Inc.(US) Basic Information, Manufacturing Base and Competitors
Table 32. Affymetrix Inc.(US) Major Business
Table 33. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 34. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Johnson & Johnson(US) Basic Information, Manufacturing Base and Competitors
Table 36. Johnson & Johnson(US) Major Business
Table 37. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 38. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Thermo Fisher Scientific Inc.(US) Basic Information, Manufacturing Base and Competitors
Table 40. Thermo Fisher Scientific Inc.(US) Major Business
Table 41. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 42. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GE Healthcare(England) Basic Information, Manufacturing Base and Competitors
Table 44. GE Healthcare(England) Major Business
Table 45. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product and Services
Table 46. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Life Technologies Corp.(US) Basic Information, Manufacturing Base and Competitors
Table 48. Life Technologies Corp.(US) Major Business
Table 49. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 50. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Luminex Corp.(US) Basic Information, Manufacturing Base and Competitors
Table 52. Luminex Corp.(US) Major Business
Table 53. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 54. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Cepheid Inc.(US) Basic Information, Manufacturing Base and Competitors
Table 56. Cepheid Inc.(US) Major Business
Table 57. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 58. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Allegro Diagnostics Corp.(Brazil) Basic Information, Manufacturing Base and Competitors
Table 60. Allegro Diagnostics Corp.(Brazil) Major Business
Table 61. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product and Services
Table 62. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Next Generation Cancer Diagnostic Devices Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 64. Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Next Generation Cancer Diagnostic Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Next Generation Cancer Diagnostic Devices Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 67. Head Office and Next Generation Cancer Diagnostic Devices Production Site of Key Manufacturer
Table 68. Next Generation Cancer Diagnostic Devices New Entrant and Capacity Expansion Plans
Table 69. Next Generation Cancer Diagnostic Devices Mergers & Acquisitions in the Past Five Years
Table 70. Global Next Generation Cancer Diagnostic Devices Sales by Region (2016-2021e) & (K Pcs)
Table 71. Global Next Generation Cancer Diagnostic Devices Sales by Region (2021-2026) & (K Pcs)
Table 72. Global Next Generation Cancer Diagnostic Devices Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Next Generation Cancer Diagnostic Devices Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021e) & (K Pcs)
Table 75. Global Next Generation Cancer Diagnostic Devices Sales by Type (2021-2026) & (K Pcs)
Table 76. Global Next Generation Cancer Diagnostic Devices Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Next Generation Cancer Diagnostic Devices Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Next Generation Cancer Diagnostic Devices Price by Type (2016-2021e) & (USD/Pcs)
Table 79. Global Next Generation Cancer Diagnostic Devices Price by Type (2021-2026) & (USD/Pcs)
Table 80. Global Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021e) & (K Pcs)
Table 81. Global Next Generation Cancer Diagnostic Devices Sales by Application (2021-2026) & (K Pcs)
Table 82. Global Next Generation Cancer Diagnostic Devices Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Next Generation Cancer Diagnostic Devices Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Next Generation Cancer Diagnostic Devices Price by Application (2016-2021e) & (USD/Pcs)
Table 85. Global Next Generation Cancer Diagnostic Devices Price by Application (2021-2026) & (USD/Pcs)
Table 86. North America Next Generation Cancer Diagnostic Devices Sales by Country (2016-2021e) & (K Pcs)
Table 87. North America Next Generation Cancer Diagnostic Devices Sales by Country (2021-2026) & (K Pcs)
Table 88. North America Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Next Generation Cancer Diagnostic Devices Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021e) & (K Pcs)
Table 91. North America Next Generation Cancer Diagnostic Devices Sales by Type (2021-2026) & (K Pcs)
Table 92. North America Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021e) & (K Pcs)
Table 93. North America Next Generation Cancer Diagnostic Devices Sales by Application (2021-2026) & (K Pcs)
Table 94. Europe Next Generation Cancer Diagnostic Devices Sales by Country (2016-2021e) & (K Pcs)
Table 95. Europe Next Generation Cancer Diagnostic Devices Sales by Country (2021-2026) & (K Pcs)
Table 96. Europe Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Next Generation Cancer Diagnostic Devices Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021e) & (K Pcs)
Table 99. Europe Next Generation Cancer Diagnostic Devices Sales by Type (2021-2026) & (K Pcs)
Table 100. Europe Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021e) & (K Pcs)
Table 101. Europe Next Generation Cancer Diagnostic Devices Sales by Application (2021-2026) & (K Pcs)
Table 102. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Region (2016-2021e) & (K Pcs)
Table 103. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Region (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021e) & (K Pcs)
Table 107. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Type (2021-2026) & (K Pcs)
Table 108. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021e) & (K Pcs)
Table 109. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Application (2021-2026) & (K Pcs)
Table 110. South America Next Generation Cancer Diagnostic Devices Sales by Country (2016-2021e) & (K Pcs)
Table 111. South America Next Generation Cancer Diagnostic Devices Sales by Country (2021-2026) & (K Pcs)
Table 112. South America Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Next Generation Cancer Diagnostic Devices Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021e) & (K Pcs)
Table 115. South America Next Generation Cancer Diagnostic Devices Sales by Type (2021-2026) & (K Pcs)
Table 116. South America Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021e) & (K Pcs)
Table 117. South America Next Generation Cancer Diagnostic Devices Sales by Application (2021-2026) & (K Pcs)
Table 118. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Country (2016-2021e) & (K Pcs)
Table 119. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Country (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021e) & (K Pcs)
Table 123. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Type (2021-2026) & (K Pcs)
Table 124. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021e) & (K Pcs)
Table 125. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Application (2021-2026) & (K Pcs)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Next Generation Cancer Diagnostic Devices Typical Distributors
Table 129. Next Generation Cancer Diagnostic Devices Typical Customers
List of Figures
Figure 1. Next Generation Cancer Diagnostic Devices Picture
Figure 2. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2020
Figure 3. Next Generation Sequencing
Figure 4. qPCR & Multiplexing
Figure 5. Lab-on- a- chip (LOAC)
Figure 6. Protein Microarrays
Figure 7. DNA Microarrays
Figure 8. Reverse Transcriptase-PCR (RT-PCR)
Figure 9. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2020
Figure 10. Biomarker Development
Figure 11. CTC Analysis
Figure 12. Proteomic Analysis
Figure 13. Epigenetic Analysis
Figure 14. Genetic Analysis
Figure 15. Global Next Generation Cancer Diagnostic Devices Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 16. Global Next Generation Cancer Diagnostic Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Next Generation Cancer Diagnostic Devices Sales (2016-2026) & (K Pcs)
Figure 18. Global Next Generation Cancer Diagnostic Devices Price by Type (2016-2026) & (USD/Pcs)
Figure 19. Global Next Generation Cancer Diagnostic Devices Production Capacity (2016-2026) & (K Pcs)
Figure 20. Global Next Generation Cancer Diagnostic Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Next Generation Cancer Diagnostic Devices Market Drivers
Figure 22. Next Generation Cancer Diagnostic Devices Market Restraints
Figure 23. Next Generation Cancer Diagnostic Devices Market Trends
Figure 24. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturer in 2020
Figure 25. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Manufacturer in 2020
Figure 26. Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Next Generation Cancer Diagnostic Devices Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Next Generation Cancer Diagnostic Devices Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2026)
Figure 30. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2016-2026)
Figure 31. North America Next Generation Cancer Diagnostic Devices Revenue (2016-2026) & (USD Million)
Figure 32. Europe Next Generation Cancer Diagnostic Devices Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue (2016-2026) & (USD Million)
Figure 34. South America Next Generation Cancer Diagnostic Devices Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue (2016-2026) & (USD Million)
Figure 36. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2026)
Figure 37. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2016-2026)
Figure 38. Global Next Generation Cancer Diagnostic Devices Price by Type (2016-2026) & (USD/Pcs)
Figure 39. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2026)
Figure 40. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2016-2026)
Figure 41. Global Next Generation Cancer Diagnostic Devices Price by Application (2016-2026) & (USD/Pcs)
Figure 42. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2026)
Figure 43. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2026)
Figure 44. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2016-2026)
Figure 45. North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2016-2026)
Figure 46. United States Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2026)
Figure 50. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2026)
Figure 51. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2016-2026)
Figure 52. Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2016-2026)
Figure 53. Germany Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2016-2026)
Figure 62. China Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2026)
Figure 69. South America Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2026)
Figure 70. South America Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2016-2026)
Figure 71. South America Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source

---